Skip to main content

ALXN Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Alexion Pharmaceuticals, Inc. News

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

Moderna Gets European Nod for Adolescent COVID-19 Vaccine

European regulators 'adopted a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine,' Moderna says.

Five Top Stock Gainers for Friday: Moderna, MoneyGram, GX Acquisition

Moderna, MoneyGram, GX Acquisition, Byrna Technologies and Zynex are five top stock gainers for Friday.

Premarket Movers Friday: Moderna, Didi, MoneyGram

Stocks moving in premarket trading Friday include Moderna, Didi Global, MoneyGram, Intel and GameStop.

Moderna Surges to Record High as Vaccine Maker Added to S&P 500

Moderna will replace Alexion Pharmaceuticals in the S&P 500 benchmark following that group's $39 billion takeover by Britain's AstraZeneca in December of last year.

Breaking News

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.

Netflix Lays Offs More Employees To Cut Costs

Netflix layoffs continue as the streaming giant executes a plan to cope with slow revenue growth.

These Five Things Could Help (or Hurt) Internet Stocks

Bank of America analysts outline some of the biggest issues facing Amazon, Alphabet, Meta and other internet-related stocks.